Navigation Links
Avillion LLP Receives Initial Funding From Abingworth and Clarus
Date:1/28/2013

LONDON, January 28, 2013 /PRNewswire/ --

Avillion LLP, which focuses on clinical co-development of therapeutics, today announced that it has received initial funding from Abingworth LLP and Clarus Ventures.

Avillion, based in London, UK, is partnering with pharmaceutical and biotechnology companies to co-developand finance latestage therapeutics. The company will use its clinical development and regulatory expertise to obtain global approvalsfor a broad range of drugs and biologics.

Lewis Cameron , theCEO of Avillion, commented: "Avillion offers pharma and biotech companies a compelling option to partner late stage drug approval projects globally. We have an experienced team focused on global drug development and approval, with the capability to optimise CRO management."

The management team is led by Lewis Cameron (CEO), who has held senior executive positions in CRO companies,including Chiltern International, Clearstone and LabCorp. Dr Allison Jeynes-Ellis (CMO) has over 20 years experience running clinical trials for pharmaceutical companies,including Wyeth and BMS, and has been extensively involved in health technology appraisals across various countries. Graham Higson (VP, Regulatory) has three decades of regulatory experience, including 5 years as the global head of regulatory affairs at AstraZeneca. John Bradshaw (CFO) provides financial services to life sciences companies and has extensive experience in dealing with complex accounting and finance issues relevant to the pharmaceutical industry.

Genghis Lloyd-Harris , a partner at Abingworth, said: "We founded Avillion and incubated the company in our London office. The Avillion team has exceptionally broad and deep
'/>"/>

SOURCE Avillion LLP
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. St. Mark’s School Receives $4.8 Million Gift from Tech Pioneer Graduate
2. RiboMed Receives Three Additional Patents for Disease Diagnostics Methods
3. RiboMed Receives Three Additional Patents for Disease Diagnostics Methods
4. BioNeutral Group Receives Positive Testing Results From A Global Independent Laboratory For Its Ygiene Sterilant Against Anthrax Spores
5. iBio, Inc. Receives Notice from NYSE MKT Staff that Company Currently is Below Certain Continued Listing Standards
6. AtheroNova Receives Notice of Issuance of Its U.S. Patent 8,304,383
7. Ceres Receives $3.5 million from USAID for Trait Stacks
8. Creabilis Receives Prestigious Technology Strategy Board Biomedical Catalyst Award
9. Hertz Fellow, Grant I. Gillary, Receives Hertz Foundation-George Lerman Fellowship
10. Sinovac Biotech Receives GMP Certification for Mumps Vaccine Production Facility
11. Lifeline Biotechnologies Receives Patent for Methods to Collect and Analyze Breast Thermal Data to Determine Suspect Conditions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... ... August 26, 2015 , ... Lee Biosolutions, a ... development and manufacture of highly valued cardiac markers used in early detection of ... with protein chemistry has led to the development and commercialization of important cardiac ...
(Date:8/26/2015)... 26, 2015 Israel Proves Its Place in ... st place  Wayerz comes in 5 th ... by venture capital fund JVP, with Chinese consulting firm ... China , Israel , ... Impressive achievement for the Israeli representatives in the final round ...
(Date:8/26/2015)... (PRWEB) , ... August 26, 2015 , ... PRC ... to develop new business relationships with local sponsors in southern California. The Clinical Trial ... their drug development processes and regulatory pathways., , Stem ...
(Date:8/25/2015)... ... August 25, 2015 , ... Vets ... in Knapp, Wis. The company has added a AS16 Sharples centrifuge to harvest ... collection during bacterial or fungal fermentation process development. , The new centrifuge ...
Breaking Biology Technology:Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 4Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 5Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 6PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 3New centrifuge and fermentor expand product development capacity at Vets Plus 2
... July 19, 2011 COPAN will be holding a ... Annual Meeting. The workshop will be held at the ... AM. This program is approved for 1.5 ACCENT® Continuing ... charge and open to AACC attendees ( http://conta.cc/jI0TSV ). ...
... 19, 2011 , Convergence Pharmaceuticals Limited ... high value analgesic,medicines, today announces that the Phase II ... with lumbosacral,radiculopathy (LSR) has started. LSR is ... nerve roots in the lumbar region of the spine. ...
... from cadmium and selenium degrade in soil, unleashing toxic ... at Buffalo study has found. The research, accepted ... Technology , demonstrates the importance of learning more about ... with the environment after disposal, said Diana Aga, the ...
Cached Biology Technology:COPAN Announces Workshop on Automated Specimen Processing, Digital Workup and Reporting in Microbiology During AACC Clinical Lab Expo 2Convergence Pharmaceuticals Announces Start of Phase II Study for its Selective Nav 1.7 blocker CNV1014802 2Convergence Pharmaceuticals Announces Start of Phase II Study for its Selective Nav 1.7 blocker CNV1014802 3Convergence Pharmaceuticals Announces Start of Phase II Study for its Selective Nav 1.7 blocker CNV1014802 4Cadmium selenide quantum dots degrade in soil, releasing their toxic guts, study finds 2Cadmium selenide quantum dots degrade in soil, releasing their toxic guts, study finds 3
(Date:8/10/2015)... , August 10, 2015 ... Eye Tracking Technology for more than two decades, announces ... for integration into all consumer display formats. The SMI ... integration of eye tracking into consumer tablets, laptops, desktop ... smart glasses. Omnivision,s leading sensor technology contributes to the ...
(Date:8/6/2015)... REDWOOD CITY, Calif. , Aug. 6, 2015 ... (D-Silicon Valley) will visit Crossmatch ™ to ... secure networks and protect data. Crossmatch is a ... solutions whose technologies and expertise are helping federal ... operational efficiency and security.   "The ...
(Date:8/6/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ... today announced collaboration with Microsoft on biometric fingerprint ... leveraged Synaptics, deep expertise in human interface which ... Through stringent testing, Synaptics, advanced image sensing ... Precision TouchPad (PTP) specification empowering OEMs with Windows ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Rep. Honda to Visit Crossmatch in Redwood City 2Synaptics Chosen for Human Interface Co-Development on Windows 10 2
... for sleeping sickness, carried out by the international humanitarian ... research arm, Epicentre, have now been published in the ... sickness affects many tens of thousands of people each ... for which there are few treatment options. The most commonly ...
... are releasing methane, a greenhouse gas, at rates that appear ... acting as a positive feedback to climate warming, said Katey ... , Walter's project is the first time this type of ... estimates were missing a very large and important component of ...
... As part of the international Census of Marine Life ... on an expedition to explore coral reef biodiversity in ... Northwestern Hawaiian Islands Marine National Monument. Led by ... Fisheries Science Center, with funding from NOAA's Coral Reef ...
Cached Biology News:Siberian lakes burp 'time-bomb' greenhouse gas 2First Biodiversity Census of coral reef ecosystems in the NW Hawaiian Islands 2First Biodiversity Census of coral reef ecosystems in the NW Hawaiian Islands 3
Rat CNTF R alpha Affinity Purified Polyclonal Ab...
Human MFRP MAb (Clone 291218)...
Human RELT/TNFRSF19L Affinity Purified Polyclonal Ab...
... NOS activity by monitoring the conversion of ... simple, sensitive, and specific for NOS activity ... and purified enzyme preparations. The kit includes ... reactions. Radiolabeled arginine and NADPH are not ...
Biology Products: